insights_auto
Pse është rritur BOT 22,22%?
Zhytu më thellëchevron_right
BOT:ASX
Botanix Pharmaceuticals Ltd
0,011 A$
arrow_upward
+22,22%(+0,0020) 1D
5 nën, 4:10:30 m.d., GMT+11 · AUD
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për BOT...
Hap
0,01 A$
I lartë
0,01 A$
I ulët
0,01 A$
Kapitalizimi i tregut
30,39 mln
Vëllimi mesatar
9,08 mln
Vëllimi
7,72 mln
Maksimumi 52-javor
0,15 A$
Minimumi 52-javor
0,01 A$
Fitimet për aksion
-0,03 A$
Aksionet në qarkullim
2,76 mld
Numri i punonjësve
11
Hap
0,01 A$
I lartë
0,01 A$
I ulët
0,01 A$
Kapitalizimi i tregut
30,39 mln
Vëllimi mesatar
9,08 mln
Vëllimi
7,72 mln
Maksimumi 52-javor
0,15 A$
Minimumi 52-javor
0,01 A$
Fitimet për aksion
-0,03 A$
Aksionet në qarkullim
2,76 mld
Numri i punonjësve
11
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
www.marketscreener.com
·
23 minuta më parë
Primech Holdings (Nasdaq: PMEC) Secures Approximately US$1.67 Million in Cleaning Services Contracts Running to 2029 Across Singapore’s Industrial and Residential Sectors
FinancialContent
·
30 minuta më parë
CRA (NASDAQ:CRAI) reports strong Q3 2026, full-year sales guidance is optimistic
PR Newswire Canada
·
13 minuta më parë
NYSE Chair Sharon Bowen Earns Lifetime Achievement Award: NYSE Content Update
Yahoo Finance
·
15 minuta më parë
Nova (NASDAQ:NVMI) Q3: beats on revenue but stock drops
Profili
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
Rreth Botanix Pharmaceuticals Ltd